TWiV 817: COVID-19 clinical update #84 with Dr. Daniel Griffin

<p>In COVID-19 clinical update #84, Dr. Griffin discusses childrens’ antibody response to vaccination, phase 3 results of Novavax vaccine, heterologous vaccination, antithrombotic therapy, EUA for molnupiravir, phase 3 results of AZD7442, serum ferritin levels and outcomes, heparin therapy, and WHO strategy for global vaccination.</p> <div class="fluid-width-video-wrapper">Hosts: <a href= "http://parasiteswithoutborders.com/">Daniel Griffin</a> and <a href="http://en.wikipedia.org/wiki/Vincent_Racaniello">Vincent Racaniello</a></div> <div class="fluid-width-video-wrapper"> </div> <div class="fluid-width-video-wrapper">Subscribe (free): <a href= "http://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?id=300973784">iTunes</a>, <a href="https://www.google.com/podcasts?feed=aHR0cDovL3R3aXYubWljcm9iZXdvcmxkLmxpYnN5bnByby5jb20vdHdpdg%3D%3D">Google Podcasts</a>, <a href= "http://twiv.microbeworld.libsynpro.com/twiv">RSS</a>, <a href="http://eepurl.com/Gcw59">email</a></div> <p>Become a <a href= "https://www.microbe.tv/contribute">patron</a> of TWiV!</p> <h3><strong>Links for this episode</strong></h3> <ul> <li><a href= "https://www.biorxiv.org/content/10.1101/2021.10.07.463592v1">Antibody profiles</a> after mRNA vaccination in children (bioRxiv)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2021.02.26.21252482v1">Novavax vaccine</a> phase 3 results (medRxiv)</li> <li><a href= "https://www.medrxiv.org/content/10.1101/2021.10.10.21264827v1">Heterologous</a> vaccine boosters (medRxiv)</li> <li><a href= "https://jamanetwork.com/journals/jama/fullarticle/2785218">Antithrombotic therapy</a> outcomes (JAMA)</li> <li><a href= "https://www.fda.gov/news-events/press-announcements/fda-hold-advisory-committee-meeting-discuss-merck-and-ridgebacks-eua-application-covid-19-oral"> Molnupiravir EUA</a> submitted (Merck)</li> <li><a href= "https://www.astrazeneca.com/media-centre/press-releases/2021/azd7442-phiii-trial-positive-in-covid-outpatients.html"> AZD7442 phase 3</a> results (AstraZeneca)</li> <li><a href= "ht